Knüsel O
Z Rheumatol. 1984 Mar-Apr;43(2):75-82.
Due to the relative increase of age-diabetes and to the different forms of rheumatic diseases, long-term medicament therapy and the question of possible interactions between oral antidiabetic drugs ( OAD ) and nonsteroidal anti-inflammatory drugs (NSAID) become more important. Unfortunately there exist studies on most of the well-known NSAID, but carried out on different conditions. The present study is intended to summarize the results at hand and to evaluate them in a certain sense. From almost all the NSAID, except from the salicylates and those connected with, as well as the pyrazolones, one may say, based on published data and long-term experience, that interactions with the OAD in use nowadays are not to be expected unless without clinical relevance.
由于老年糖尿病患者数量的相对增加以及风湿性疾病的不同形式,长期药物治疗以及口服抗糖尿病药物(OAD)与非甾体抗炎药(NSAID)之间可能存在的相互作用问题变得更加重要。遗憾的是,针对大多数知名NSAID的研究都是在不同条件下进行的。本研究旨在总结现有结果并在一定程度上对其进行评估。根据已发表的数据和长期经验,几乎所有NSAID(除了水杨酸盐以及与之相关的药物和吡唑啉酮类),可以说,除非没有临床相关性,否则与目前使用的OAD之间预计不会发生相互作用。